On heels of Bain buyout, Tanabe inks deal to sell manufacturing unit and 17 drugs to Towa

While not on the same scale of some of Big Pharma’s major carveouts in recent years, the deal follows a noticeable pattern in which diversified drugmakers have simplified their structures to focus more on innovative medicines.

Source: FiercePharma